241
Participants
Start Date
October 31, 2022
Primary Completion Date
July 17, 2025
Study Completion Date
July 31, 2026
Brepocitinib
Oral Brepocitinib
Placebo
Oral Placebo
Clinical Trial Site, Tainan City
Clinical Trial Site, Sofia
Clinical Trial Site, Caba
Clinical Trial Site, Leuven
Clinical Trial Site, Plovdiv
Clinical Trial Site, Plovdiv
Clinical Trial Site, Plovdiv
Clinical Trial Site, Debrecen
Clinical Trial Site, Mendoza
Clinical Trial Site, Szeged
Clinical Trial Site, Pécs
Clinical Trial Site, Taipei
Clinical Trial Site, New York
Clinical Trial Site, New York
Clinical Trial Site, Berlin
Clinical Trial Site, Torino
Clinical Trial Site, Belgrade
Clinical Trial Site, Manhasset
Clinical Trial Site, Pittsburgh
Clinical Trial Site, Berlin
Clinical Trial Site, Suwon
Clinical Trial Site, Philadelphia
Clinical Trial Site, Baltimore
Clinical Trial Site, Pavia
Clinical Trial Site, Madrid
Clinical Trial Site, Marietta
Clinical Trial Site, Atlanta
Clinical Trial Site, Augusta
Clinical Trial Site, Jacksonville
Clinical Trial Site, Gainesville
Clinical Trial Site, Plantation
Clinical Trial Site, Boynton Beach
Clinical Trial Site, Tampa
Clinical Trial Site, Istanbul
Clinical Trial Site, Izmir
Clinical Trial Site, Jackson
Clinical Trial Site, Taichung
Clinical Trial Site, İzmit
Clinical Trial Site, Cleveland
Clinical Trial Site, Guadalajara
Clinical Trial Site, Essen
Clinical Trial Site, Cincinnati
Clinical Trial Site, Ann Arbor
Clinical Trial Site, Iowa City
Clinical Trial Site, Tel Litwinsky
Clinical Trial Site, Mainz
Clinical Trial Site, Minneapolis
Clinical Trial Site, Rochester
Clinical Trial Site, Chicago
Clinical Trial Site, Monterrey
Clinical Trial Site, Kansas City
Clinical Trial Site, New Orleans
Clinical Trial Site, Bari
Clinical Trial Site, New Orleans
Clinical Trial Site, Oklahoma City
Clinical Trial Site, Irving
Clinical Trial Site, Houston
Clinical Trial Site, San Luis Potosí City
Clinical Trial Site, Austin
Clinical Trial Site, Freiburg im Breisgau
Clinical Trial Site, Aurora
Clinical Trial Site, Denver
Clinical Trial Site, Phoenix
Clinical Trial Site, Scottsdale
Clinical Trial Site, Scottsdale
Clinical Trial Site, Los Angeles
Clinical Trial Site, Irvine
Clinical Trial Site, San Francisco
Clinical Trial Site, Mérida
Clinical Trial Site, Portland
Clinical Trial Site, Cluj-Napoca
Clinical Trial Site, Kaohsiung City
Clinical Trial Site, Poria – Neve Oved
Clinical Trial Site, Haifa
Clinical Trial Site, Concepción
Clinical Trial Site, Temuco
Clinical Trial Site, Tel Aviv
Clinical Trial Site, Santiago
Clinical Trial Site, Ashkelon
Clinical Trial Site, Santiago
Clinical Trial Site, Recoleta
Clinical Trial Site, Boston
Clinical Trial Site, Quilmes
Clinical Trial Site, Vancouver
Clinical Trial Site, Newmarket
Clinical Trial Site, Prague
Clinical Trial Site, Dresden
Clinical Trial Site, Roma
Clinical Trial Site, Mexico City
Clinical Trial Site, Nijmegen
Clinical Trial Site, Amsterdam
Clinical Trial Site, Bialystok
Clinical Trial Site, Krakow
Clinical Trial Site, Lublin
Clinical Trial Site, Lublin
Clinical Trial Site, Nowa Sól
Clinical Trial Site, Poznan
Clinical Trial Site, Warsaw
Clinical Trial Site, Vila Nova de Gaia
Clinical Trial Site, Guimarães
Clinical Trial Site, Lisbon
Clinical Trial Site, Porto
Clinical Trial Site, Bucharest
Clinical Trial Site, Seoul
Clinical Trial Site, Ankara
Clinical Trial Site, Antalya
Clinical Trial Site, Bath
Clinical Trial Site, Manchester
Clinical Trial Site, Wolverhampton
Lead Sponsor
Priovant Therapeutics, Inc.
INDUSTRY